Good morning :)
Place Order
Add to Watchlist

Indraprastha Medical Corporation Ltd

INDRAMEDCO Share Price

414.250.06% (-0.25)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹3,799 cr, stock is ranked 839

Stock is 3.45x as volatile as Nifty

How to use scorecard? Learn more

With a market cap of ₹3,799 cr, stock is ranked 839

Stock is 3.45x as volatile as Nifty

INDRAMEDCO Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
23.607.951.09%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
37.786.460.86%

INDRAMEDCO Analyst Ratings & Forecast

Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

INDRAMEDCO Company Profile

Indraprastha Medical Corporation Limited is engaged in healthcare business.

INDRAMEDCO Similar Stocks (Peers)

Compare with peers 
PE Ratio
103.75
1Y Return
36.97%
Buy Reco %
75.00
PE Ratio
111.28
1Y Return
18.51%
Buy Reco %
86.21
PE Ratio
70.58
1Y Return
54.10%
Buy Reco %
100.00
PE Ratio
44.33
1Y Return
35.95%
Buy Reco %
66.67
PE Ratio
66.09
1Y Return
4.51%
Buy Reco %
71.43
Compare with Peers

INDRAMEDCO Forecasts

INDRAMEDCO Forecast

Price

Revenue

Earnings

INDRAMEDCO

Income

Balance Sheet

Cash Flow

INDRAMEDCO Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 9.85%, vs industry avg of 10.01%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 2.15% to 1.98%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 34.26%, vs industry avg of 42.91%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue766.18753.45788.64831.46614.06891.281,108.701,261.591,379.011,379.01
Raw Materialssubtract0.000.000.000.000.000.000.000.001,112.091,112.09
Power & Fuel Costsubtract20.9119.2619.7021.1617.1820.5622.7426.01
Employee Costsubtract190.26194.01200.21213.93197.71213.92246.70261.61
Selling & Administrative Expensessubtract76.5872.2978.2083.66186.62292.12407.26462.43
Operating & Other expensessubtract399.17394.31409.28425.63171.60247.26271.27301.29
Depreciation/Amortizationsubtract30.5330.6829.7532.9733.3234.9439.2740.0844.3344.33
Interest & Other Itemssubtract7.918.906.875.923.343.414.284.066.276.27
Taxes & Other Itemssubtract14.5712.9016.214.571.9620.4531.0342.1555.3355.33
EPS2.862.303.104.760.256.399.4013.5217.5617.56
DPS1.801.501.600.000.002.503.004.504.504.50
Payout ratio0.630.650.520.000.000.390.320.330.260.26

INDRAMEDCO Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

INDRAMEDCO Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Indraprastha Medical Corporation Ltd23.607.951.09%
Max Healthcare Institute Ltd103.7513.280.13%
Apollo Hospitals Enterprise Ltd111.2813.660.23%
Fortis Healthcare Ltd70.586.390.14%

INDRAMEDCO Stock Price Comparison

Compare INDRAMEDCO with any stock or ETF
Compare INDRAMEDCO with any stock or ETF
INDRAMEDCO
Loading...

INDRAMEDCO Shareholdings

INDRAMEDCO Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

INDRAMEDCO Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

INDRAMEDCO Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding51.00%2.62%0.94%2.94%42.51%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

INDRAMEDCO Shareholding History

Dec '23MarJunSepDec '24Mar0.95%1.08%1.70%2.64%2.88%2.94%

Mutual Funds Invested in INDRAMEDCO

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 2 Mutual Funds holding Indraprastha Medical Corporation Ltd



Funds (Top 2)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
2.4982%0.36%-0.01%60/103 (+12)
0.0007%0.14%-0.00%65/109 (-3)

Compare 3-month MF holding change on Screener

INDRAMEDCO Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing INDRAMEDCO stock

Looks like this stock is not in any smallcase yet.

INDRAMEDCO Events

INDRAMEDCO Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

INDRAMEDCO Upcoming Dividends

No upcoming dividends are available

INDRAMEDCO Past Dividends

Cash Dividend

Ex DateEx DateSep 13, 2024

Final
Final | Div/Share: ₹4.50

Dividend/Share

4.50

Ex DateEx Date

Sep 13, 2024

Cash Dividend

Ex DateEx DateSep 15, 2023

Final
Final | Div/Share: ₹3.00

Dividend/Share

3.00

Ex DateEx Date

Sep 15, 2023

Cash Dividend

Ex DateEx DateSep 15, 2022

Final
Final | Div/Share: ₹2.50

Dividend/Share

2.50

Ex DateEx Date

Sep 15, 2022

Cash Dividend

Ex DateEx DateSep 12, 2019

Final
Final | Div/Share: ₹1.60

Dividend/Share

1.60

Ex DateEx Date

Sep 12, 2019

Cash Dividend

Ex DateEx DateSep 12, 2018

Final
Final | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Sep 12, 2018

INDRAMEDCO Stock News & Opinions

Corporate
Board of Indraprastha Medical Corporation recommends final dividend

Indraprastha Medical Corporation announced that the Board of Directors of the Company at its meeting held on 16 May 2025, inter alia, have recommended the final dividend of Rs 4.5 per equity Share (i.e. 45%) , subject to the approval of the shareholders.Powered by Capital Market - Live

6 days agoCapital Market - Live
Earnings
Indraprastha Medical Corporation standalone net profit rises 31.57% in the March 2025 quarter

Net profit of Indraprastha Medical Corporation rose 31.57% to Rs 41.01 crore in the quarter ended March 2025 as against Rs 31.17 crore during the previous quarter ended March 2024. Sales rose 6.04% to Rs 333.75 crore in the quarter ended March 2025 as against Rs 314.73 crore during the previous quarter ended March 2024. For the full year,net profit rose 29.87% to Rs 160.99 crore in the year ended March 2025 as against Rs 123.96 crore during the previous year ended March 2024. Sales rose 8.97% to Rs 1356.36 crore in the year ended March 2025 as against Rs 1244.70 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales333.75314.73 6 1356.361244.70 9 OPM %18.3715.39 -18.0115.53 - PBDT66.1851.77 28 260.65206.19 26 PBT55.2741.56 33 216.32166.11 30 NP41.0131.17 32 160.99123.96 30 Powered by Capital Market - Live

6 days agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to discuss results

Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 16 May 2025.Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Spotlight
ICRA reaffirms ratings of Indraprastha Medical Corp; maintains 'stable' outlook

The agency has also affirmed the company's short term rating at '[ICRA] A1+'. ICRA stated that the rating action factors in Indraprastha Medical Corporation Limited (IMCL)'s established presence and strong market position in the NCR region, its healthy operating metrics and its robust financial profile. The ratings also factor in IMCL's revenue diversification across specialities, including oncology, neurology, cardiology and nephrology, among others. The financial risk profile remains comfortable as reflected by minimal gearing, robust debt protection indicators and a strong liquidity profile. Further, the ratings factor in the strong parentage of Apollo Hospitals Enterprise Limited (AHEL) along with its promoters, holding a 25% stake in IMCL. The entity has significant operational, financial and managerial linkages with AHEL. Apollo Hospitals is among the leading healthcare players, operating one of the largest hospital chains in the country. However, the ratings remain constrained by the geographical and asset concentration risks, as IMCL's operations are concentrated across two hospitals in the National Capital Region (NCR). Like other entities in the sector, IMCL remains exposed to regulatory risks, with previous restrictions imposed by various authorities. The ratings also factor in the competitive pressures and the necessity to retain medical talent in an ever-evolving market. Incorporated in 1988 as a JV between Apollo Hospitals Enterprise (AHEL) and the Delhi Government, Indraprastha Medical Corporation (IMCL) is a 749-bedded, super speciality tertiary care hospital in New Delhi and Noida. The scrip gained 3.09% to currently trade at Rs 415.30 on the BSE. Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to conduct board meeting

Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 3 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Indraprastha Medical Corporation standalone net profit rises 29.07% in the September 2024 quarter

Net profit of Indraprastha Medical Corporation rose 29.07% to Rs 42.40 crore in the quarter ended September 2024 as against Rs 32.85 crore during the previous quarter ended September 2023. Sales rose 10.35% to Rs 349.82 crore in the quarter ended September 2024 as against Rs 317.00 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales349.82317.00 10 OPM %18.1915.89 - PBDT68.1053.68 27 PBT56.9343.65 30 NP42.4032.85 29 Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Indraprastha Medical Corporation announces board meeting date

Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 30 October 2024.Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to hold AGM

Indraprastha Medical Corporation announced that the 36th Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live
Earnings
Indraprastha Medical Corporation standalone net profit rises 46.79% in the June 2024 quarter

Net profit of Indraprastha Medical Corporation rose 46.79% to Rs 44.77 crore in the quarter ended June 2024 as against Rs 30.50 crore during the previous quarter ended June 2023. Sales rose 13.49% to Rs 347.86 crore in the quarter ended June 2024 as against Rs 306.51 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales347.86306.51 13 OPM %19.3015.42 - PBDT70.6350.04 41 PBT59.5940.23 48 NP44.7730.50 47 Powered by Capital Market - Live

9 months agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to declare Quarterly Result

Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 5 August 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live

Frequently asked questions

  1. What is the share price of Indraprastha Medical Corporation Ltd (INDRAMEDCO) today?

    The share price of INDRAMEDCO as on 23rd May 2025 is ₹414.25. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?

    The past returns of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share are
    • Past 1 week: 1.73%
    • Past 1 month: -2.69%
    • Past 3 months: 4.54%
    • Past 6 months: -1.11%
    • Past 1 year: 69.36%
    • Past 3 years: 609.76%
    • Past 5 years: 1015.75%

  3. What are the peers or stocks similar to Indraprastha Medical Corporation Ltd (INDRAMEDCO)?
  4. What is the dividend yield % of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?

    The current dividend yield of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is 1.09.

  5. What is the market cap of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is ₹3799.85 Cr as of 23rd May 2025.

  6. What is the 52 week high and low of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?

    The 52-week high of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is ₹572 and the 52-week low is ₹211.30.

  7. What is the PE and PB ratio of Indraprastha Medical Corporation Ltd (INDRAMEDCO) stock?

    The P/E (price-to-earnings) ratio of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is 23.60. The P/B (price-to-book) ratio is 7.95.

  8. Which sector does Indraprastha Medical Corporation Ltd (INDRAMEDCO) belong to?

    Indraprastha Medical Corporation Ltd (INDRAMEDCO) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.

  9. How to buy Indraprastha Medical Corporation Ltd (INDRAMEDCO) shares?

    You can directly buy Indraprastha Medical Corporation Ltd (INDRAMEDCO) shares on Tickertape. Simply sign up, connect your demat account and place your order.